These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

812 related items for PubMed ID: 30332563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
    Hoang LN, McConechy MK, Köbel M, Han G, Rouzbahman M, Davidson B, Irving J, Ali RH, Leung S, McAlpine JN, Oliva E, Nucci MR, Soslow RA, Huntsman DG, Gilks CB, Lee CH.
    Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
    Schultheis AM, Martelotto LG, De Filippo MR, Piscuglio S, Ng CK, Hussein YR, Reis-Filho JS, Soslow RA, Weigelt B.
    Int J Gynecol Pathol; 2016 Jul; 35(4):289-300. PubMed ID: 26556035
    [Abstract] [Full Text] [Related]

  • 10. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.
    Ashley CW, Da Cruz Paula A, Kumar R, Mandelker D, Pei X, Riaz N, Reis-Filho JS, Weigelt B.
    Gynecol Oncol; 2019 Jan; 152(1):11-19. PubMed ID: 30415991
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
    Carlson J, McCluggage WG.
    Curr Opin Oncol; 2019 Sep; 31(5):411-419. PubMed ID: 31261170
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas.
    Wang M, Hui P.
    Arch Pathol Lab Med; 2021 Nov 01; 145(11):1367-1378. PubMed ID: 34673912
    [Abstract] [Full Text] [Related]

  • 17. The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
    Le Gallo M, Rudd ML, Urick ME, Hansen NF, National Institutes of Health Intramural Sequencing Center Comparative Sequencing ProgramNational Institutes of Health Intramural Sequencing Center, National Institutes of Health, Rockville, Maryland., Merino MJ, Mutch DG, Goodfellow PJ, Mullikin JC, Bell DW.
    Cancer; 2018 Jan 01; 124(1):65-73. PubMed ID: 28940304
    [Abstract] [Full Text] [Related]

  • 18. Molecular approaches for classifying endometrial carcinoma.
    Piulats JM, Guerra E, Gil-Martín M, Roman-Canal B, Gatius S, Sanz-Pamplona R, Velasco A, Vidal A, Matias-Guiu X.
    Gynecol Oncol; 2017 Apr 01; 145(1):200-207. PubMed ID: 28040204
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas.
    Momeni-Boroujeni A, Dahoud W, Vanderbilt CM, Chiang S, Murali R, Rios-Doria EV, Alektiar KM, Aghajanian C, Abu-Rustum NR, Ladanyi M, Ellenson LH, Weigelt B, Soslow RA.
    Clin Cancer Res; 2021 May 01; 27(9):2613-2623. PubMed ID: 33602681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.